Clinical Trials Browser

Phase 3 × Breast Diseases × Doxorubicin × Clear all

NCT00887536 2022-04-20

A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer

Phase 3 Completed

Adenocarcinoma, Breast Diseases, Breast Neoplasms, Carcinoma

NCT01204801 2015-09-24

Medifocus301

Phase 3 Unknown

Hyperthermia, Breast Diseases, Breast Neoplasms, Neoplasms, Neoplasms by Site